about
Brivanib, a dual FGF/VEGF inhibitor, is active both first and second line against mouse pancreatic neuroendocrine tumors developing adaptive/evasive resistance to VEGF inhibitionMolecular characterization of c-Abl/c-Src kinase inhibitors targeted against murine tumour progenitor cells that express stem cell markers.Aberrant fucosylation of glycosphingolipids in human hepatocellular carcinoma tissues.Identifying Liver Cancer and Its Relations with Diseases, Drugs, and Genes: A Literature-Based Approach.Phenyl N-(5-chloro-2-nitro-phenyl)carbamate.Advances in the design and synthesis of prazosin derivatives over the last ten years.The AKT inhibitor MK-2206 is cytotoxic in hepatocarcinoma cells displaying hyperphosphorylated AKT-1 and synergizes with conventional chemotherapyTargeting the growth factors and angiogenesis pathways: small molecules in solid tumors.Current and future management strategies for relapsed or progressive hepatoblastoma.The role and clinical implications of microRNAs in hepatocellular carcinoma.Enhanced binding to and killing of hepatocellular carcinoma cells in vitro by melittin when linked with a novel targeting peptide screened from phage display.Ubenimex suppresses Pim-3 kinase expression by targeting CD13 to reverse MDR in HCC cells.Augmentation of chemotherapeutic infusion effect by TSU-68, an oral targeted antiangiogenic agent, in a rabbit VX2 liver tumor model.
P2860
Q24616631-FA569511-C022-4F85-8256-04995C2AC2D0Q33770326-0FE5740C-14E5-4E9E-863C-D73E33FF2F5FQ34884062-39F9E0FE-ED7E-4092-92B6-E6E100B9D7CFQ36022138-163F7F87-8E5F-4CF6-8CC7-1E96DC5090DDQ36151120-FD4D27E8-1846-40FC-B59C-258BC5E7A7BAQ36827500-FBC50C99-DF4E-41D5-B49B-2ABB266C728DQ37299276-B4554E90-DDAD-4CDA-9C67-5442DF62FF74Q37863629-45E2A935-A6D8-4273-B3EA-76B3F9117133Q38019027-8F7B1C14-5069-48D3-9603-C7CD6ACCA6F1Q38056415-55985E7E-E104-419E-86A7-3615AE87AC63Q39098507-CA968F43-CCB8-4A4C-89B1-416C656F9AA3Q42700754-E1AD57DC-AD13-40CC-BD22-7978745BBA0DQ51737543-07AF41AB-6086-4A9E-9723-DE954E48EFE9
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tyrosine kinase inhibitors to treat liver cancer.
@en
Tyrosine kinase inhibitors to treat liver cancer.
@nl
type
label
Tyrosine kinase inhibitors to treat liver cancer.
@en
Tyrosine kinase inhibitors to treat liver cancer.
@nl
prefLabel
Tyrosine kinase inhibitors to treat liver cancer.
@en
Tyrosine kinase inhibitors to treat liver cancer.
@nl
P2860
P1476
Tyrosine kinase inhibitors to treat liver cancer.
@en
P2093
Hung Huynh
P2860
P356
10.1517/14728210903571659
P407
P577
2010-03-01T00:00:00Z